HealthcareNYSElarge
Institutional-grade research for retail investors
SEC EDGAR: CIK 1478242IQV stock profile & AI dashboard →

13F Pro Quality Score

61.4/100

Rank #780 of 2,961 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

42.7/100

Profitability

56.4/100

Balance Sheet

68.6/100

Earnings Quality

84.2/100

Free Cash Flow

61.0/100

Institutional Flow

41.7/100

Revenue Scale

91.2/100

Dilution Risk

46.0/100
Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

IQV Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for IQVIA HOLDINGS INC. (IQV), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores IQV at 61.4/100 on a 32-signal composite quality model, placing it at rank #780 of 2,961 stocks — the top half of the AI-ranked universe. IQV scores in the top quartile across revenue scale (91.2), earnings quality (84.2). Shareholder dilution risk is elevated at 46.0/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), IQVIA HOLDINGS INC. reports quarterly revenue of $4.2B, net income of $274.0M, an operating margin of 12.4%. Top institutional holders of IQV by reported 13-F value include BlackRock, HARRIS ASSOCIATES L P, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. IQV trades on the NYSE exchange and files with the SEC under CIK 1478242. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate IQV daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for IQVIA HOLDINGS INC. directly from SEC EDGAR. IQVIA HOLDINGS INC.'s 13F Pro composite quality score has ranged between 54 and 67 since 2021, currently 61.4 — an improving long-term trajectory across 67 quarterly and live scoring snapshots.

Fun facts about IQVIA HOLDINGS INC.

Quirks, history, and lore behind IQV — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. healthcare company · large-cap · listed on the NYSE · headquartered in North Carolina.
  • 2
    The Numbers
    Annual revenue of roughly $15 billion, with operations spanning more than 100 countries and a workforce of over 80,000 people.
  • 3
    The History
    Born from the 2016 merger of two giants — one a contract research organization, the other a healthcare data powerhouse — creating something the industry had never quite seen before.
  • 4
    The Secret
    Its real superpower is one of the world's largest repositories of anonymous patient-level health data, covering billions of records used to help drug developers run smarter trials.
  • 5
    The Lore
    It sits squarely in the clinical research outsourcing business, meaning pharma giants pay it to do the painstaking work of running clinical trials so they don't have to.
  • 6
    The Giveaway
    The name itself is a mashup of IMS Health and Quintiles — two legacy titans of pharma data and contract research — compressed into a ticker that looks like a Scrabble nightmare.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$4.2B

Net Income

Q1 2026

$274.0M

Free Cash Flow

Q1 2026

$491.0M

Operating Margin

Q1 2026

12.4%

ROIC

Q1 2026

9.3%

D/E Ratio

Q1 2026

2.55

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+5.9% YoY
$16.31BFY 2025
FY22 $14.41BFY23 $14.98BFY24 $15.40BFY25 $16.31B

Net Income

-0.9% YoY
$1.36BFY 2025
FY22 $1.09BFY23 $1.36BFY24 $1.37BFY25 $1.36B

Operating Income

-0.9% YoY
$2.18BFY 2025
FY22 $1.80BFY23 $1.98BFY24 $2.20BFY25 $2.18B

EPS (Diluted)

+4.7% YoY
$7.84FY 2025
FY22 $5.72FY23 $7.29FY24 $7.49FY25 $7.84

Total Assets

+11.3% YoY
$29.94BFY 2025
FY22 $25.34BFY23 $26.68BFY24 $26.90BFY25 $29.94B

Total Debt

+12.5% YoY
$15.72BFY 2025
FY22 $12.75BFY23 $13.67BFY24 $13.98BFY25 $15.72B

Op. Cash Flow

-2.3% YoY
$2.65BFY 2025
FY22 $2.26BFY23 $2.15BFY24 $2.72BFY25 $2.65B

Free Cash Flow

-3.0% YoY
$2.05BFY 2025
FY22 $1.59BFY23 $1.50BFY24 $2.11BFY25 $2.05B

Get alerted when IQV's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for IQVIA HOLDINGS INC. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of IQV

Companies Similar to IQV

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

ZBH

ZIMMER BIOMET HOLDINGS, INC.

64
AI score
Very similar · 23 shared holders
BDX

BECTON DICKINSON & CO

59
AI score
Very similar · 24 shared holders
MDT

Medtronic plc

69
AI score
Very similar · 25 shared holders
ABT

ABBOTT LABORATORIES

68
AI score
Very similar · 24 shared holders
EW

Edwards Lifesciences Corp

71
AI score
Very similar · 21 shared holders
SYK

STRYKER CORP

74
AI score
Very similar · 21 shared holders
ELV

Elevance Health, Inc.

61
AI score
Very similar · 29 shared holders

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

Put IQV on your watchlist

Track score changes the day IQVIA HOLDINGS INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is IQV a good stock to buy?

13F Pro's AI-powered analysis of IQVIA HOLDINGS INC. (IQV) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for IQV are available on the IQV stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. IQV is classified as a large company.

Which hedge funds own IQV?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling IQV. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of IQVIA HOLDINGS INC.'s investment landscape.